Please enable Javascript
GVHD
Nearly a Third of Patients with Chronic GVHD Able to Stop Long-Term Systemic Therapy
Leah Sherwood
Transplantation & Cellular Therapy
|
November 22, 2022
Nearly a third of patients with chronic graft-versus-host disease (GVHD) were able to discontinue long-term systemic therapy ...
Read More
Advertisement
Advertisement
Advertisement